Presentation Title: Reimagining Rare: Reconciling Opportunities of the “Most” Advanced Technologies and the Challenges of the “Most” Underserved and Undiagnosed Persons

Speaker: Durhane Wong-Rieger, PhD President & CEO Canadian Organization for Rare Disorders (CORD) Toronto, Ontario, Canada

Learning Objectives
Upon conclusion of this activity, participants should be able to:​

• Summarize rare diseases as global public health issue: prevalence, impact, status of access to diagnosis, care and treatment in high-income and lower-middle income settings
• Recognize how technology (genomics and AI) is helping find and diagnose persons living with undiagnosed rare conditions; understand strategies to advance diagnosis in lower-to-middle income settings
• Identify various challenges and emerging strategies associated with (sustainable) access to therapies
• Analyze rare disease as more than a medical issue: need for integrated comprehensive care plans addressing social, economic, work/school, psychosocial, gender, and equity issues related to living with rare
• Integrate rare and health complex patients AND integrate patients diagnosed with rare diseases and patients with precise (genomic) diagnosis; implications for treatment and healthcare systems

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.